Parenteral Nutrition Market is forecast to increase 2x to reach US$ 14 Billion by 2032

The market for parenteral nutrition accrued significant gains, being valued at over US$ 6 Billion as of 2021.The industry is expected to reach US$ 7 Billion by 2022-end, experiencing year on year increase of 16% compared to 2021. From 2022-2032, the industry is forecast to increase 2x to reach US$ 14 Billion.

Parenteral nutrition, also known as intravenous or IV nutrition, is a medical therapy that delivers essential nutrients directly into a patient's bloodstream when they are unable to obtain adequate nutrition through oral or enteral routes. This life-saving intervention has seen remarkable growth in the United States, reflecting the increasing prevalence of patients with complex medical conditions

Get a FREE Sample Copy of Report (Including TOC, List of Tables & Figures, Chart) :https://www.factmr.com/connectus/sample?flag=S&rep_id=7092

Market Overview

The parenteral nutrition market in the USA has experienced significant expansion over the past decade. The market encompasses a range of products and services, including parenteral nutrition solutions, intravenous delivery systems, and associated supplies. It plays a crucial role in healthcare settings, catering to patients with conditions like gastrointestinal disorders, cancer, organ failure, and premature infants, among others.

Key Factors Driving Growth

Rising Chronic Diseases: The escalating incidence of chronic diseases such as cancer, inflammatory bowel disease, and diabetes necessitates parenteral nutrition as a critical part of patient care. Patients with these conditions often experience compromised digestive function, making IV nutrition essential.

Aging Population: As the US population continues to age, the demand for parenteral nutrition is expected to grow. Elderly individuals are more susceptible to diseases requiring specialized nutrition, further boosting market growth.

Advancements in Healthcare: Continuous advancements in medical technology and patient care have enhanced the administration and monitoring of parenteral nutrition. These innovations make it a safer and more efficient option, encouraging healthcare professionals to use it more frequently.

Preterm Births: The prevalence of preterm births in the USA remains relatively high. Parenteral nutrition is crucial for the growth and development of premature infants, leading to a steady demand in neonatal intensive care units (NICUs).

Home-Based Care: Increasingly, parenteral nutrition is administered outside of the hospital setting, as patients and caregivers are trained to manage the treatment at home. This trend allows patients to have a more comfortable and cost-effective treatment experience.

Market Challenges

While the parenteral nutrition market in the USA is thriving, it faces certain challenges that could impact its growth trajectory.

High Cost: Parenteral nutrition can be expensive due to the need for specialized equipment, trained healthcare professionals, and ongoing monitoring. This cost can be a significant barrier, particularly for uninsured or underinsured patients.

Risk of Infections: Intravenous nutrition carries a risk of infections related to catheter use, which can be life-threatening. Healthcare providers must adhere to stringent protocols to minimize these risks.

Regulatory Compliance: The parenteral nutrition market is highly regulated by government agencies like the FDA (Food and Drug Administration). Meeting these regulations and ensuring product safety and quality can be challenging for manufacturers.

Key Players and Competitive Landscape:

Allergan Plc.
Baxter International
Vifor Pharma Group
Grifols S.A
Otsuka Pharmaceutical Co. Ltd.
Fresenius Kabi
Braun Melsungen AG
Pfizer Inc.
Sichuan Kelun Pharmaceutical Co. Ltd.
Actavis Inc.

Future Prospects

The future of the parenteral nutrition market in the USA is promising, with several factors contributing to its continued growth.

Personalized Nutrition: Advances in genetics and nutritional science are paving the way for personalized parenteral nutrition solutions. Tailored treatments can improve patient outcomes and reduce complications.

Home Infusion Services: Home-based parenteral nutrition services are expected to expand, making treatment more accessible and convenient for patients. This shift can also reduce healthcare costs associated with hospital stays.

Increased Awareness: As the importance of proper nutrition in healthcare gains more recognition, there will likely be a growing awareness of the benefits of parenteral nutrition, driving demand.

Technological Advancements: Ongoing innovations in infusion pumps, catheters, and monitoring devices will improve the safety and efficacy of parenteral nutrition.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=7092

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, industrial goods to even the most niche categories. 80% of Fortune 1000s trust us in critical decision making.

This release was published on openPR.